Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lineage Cell Therapeutics, Inc. Common Stock
(NY:
LCTX
)
1.730
UNCHANGED
Official Closing Price
Updated: 8:00 PM EDT, Oct 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lineage Cell Therapeutics, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
September 22, 2025
Via
Benzinga
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
September 08, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
5 Analysts Assess Lineage Cell Therapeutics: What You Need To Know
August 27, 2025
Via
Benzinga
A Peek at Lineage Cell Therapeutics's Future Earnings
August 11, 2025
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Lineage Cell Therapeutics Stock
March 11, 2025
Via
Benzinga
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
September 02, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss
August 26, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 15, 2025
Via
Benzinga
Lineage Cell Revenue Doubles in Q2
August 12, 2025
Via
The Motley Fool
Lineage Cell Therapeutics Inc. (NYSEARCA:LCTX) Reports Q2 2025 Revenue Beat but Wider Loss
August 12, 2025
Lineage Cell Therapeutics Q2 2025: Revenue beats estimates at $2.77M (+84.6%), but net loss widens to -$0.13. Stock dips 4.95% amid clinical progress and cash runway into 2027.
Via
Chartmill
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For August 12, 2025
August 12, 2025
Via
Benzinga
Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
August 05, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Two Biotech Stocks Poised For Big Moves On Monday
June 23, 2025
Via
Benzinga
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
June 05, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury
August 04, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
May 14, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Examining the Future: Lineage Cell Therapeutics's Earnings Outlook
May 12, 2025
Via
Benzinga
Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
May 01, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 13, 2025
May 13, 2025
Via
Benzinga
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
May 12, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Which stocks are moving after the closing bell on Wednesday?
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
April 21, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 15, 2025
Via
Benzinga
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 10, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For March 10, 2025
March 10, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.